The reported statements, read against the company's own industry.
Financials view
Market Capitalization
7.25BCNY
1.08B · vs all stocks (USD)
Updated Sep 19, 2026
Trailing P/E
212.00x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Revenue (TTM)
2.87BCNY
427.94M · vs all stocks (USD)
Updated Sep 19, 2026
Profit Margin
1.06%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Beta
0.2190x
vs all stocks
Updated Sep 19, 2026
52-Week Change
-10.26%
vs all stocks
Updated Sep 19, 2026
Market Capitalization
7.25BCNY
1.08B · vs all stocks (USD)
Updated Sep 19, 2026
Enterprise Value
8.83BCNY
1.32B · vs all stocks (USD)
Updated Sep 19, 2026
Trailing P/E
212.00x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Forward P/E
42.40x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Price to Sales (TTM)
2.55x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Price to Book (MRQ)
3.38x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Enterprise to Revenue
3.08x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Enterprise to EBITDA
25.34x
vs Medical Care Facilities peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 18.87×.Updated Sep 19, 2026
Gross Margin
28.02%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Profit Margin
1.06%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Operating Margin
6.33%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Return on Assets (TTM)
1.95%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Return on Equity (TTM)
1.72%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Revenue (TTM)
2.87BCNY
427.94M · vs all stocks (USD)
Updated Sep 19, 2026
Revenue per Share (TTM)
0.8750CNYUpdated Sep 19, 2026
Quarterly Revenue Growth
-13.50%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Gross Profit (TTM)
837.72MCNY
124.95M · vs all stocks (USD)
Updated Sep 19, 2026
EBITDA (TTM)
467.80MCNY
69.78M · vs all stocks (USD)
Updated Sep 19, 2026
Net Income (TTM)
30.54MCNY
4.55M · vs all stocks (USD)
Updated Sep 19, 2026
Quarterly Earnings Growth (YoY)
-13.52%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Operating Cash Flow (TTM)
218.93MCNY
32.66M · vs all stocks (USD)
Updated Sep 19, 2026
Levered Free Cash Flow (TTM)
-9.83MCNY
-1.47M · vs all stocks (USD)
Updated Sep 19, 2026
Payout Ratio
0.00%
vs Medical Care Facilities peers
Updated Sep 19, 2026
Minority Interest (Equity)
58.29MCNYFY2025 · Dec 31, 2025
Revenue
3.05BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
2.17BCNYFY2025 · Dec 31, 2025
Gross Profit
879.35MCNYFY2025 · Dec 31, 2025
Operating Income
275.58MCNY
41.11M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
77.96MCNYFY2025 · Dec 31, 2025
Income Tax Expense
44.48MCNYFY2025 · Dec 31, 2025
Net Income
33.48MCNYFY2025 · Dec 31, 2025
EBIT
201.39MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
467.80MCNYFY2025 · Dec 31, 2025
Research & Development
13.35MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
214.55MCNYFY2025 · Dec 31, 2025
Other Operating Expenses
36.83MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
4.51MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
123.43MCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.0094CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.0094CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
3.29BSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
3.29BSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
33.48MCNYFY2025 · Dec 31, 2025
Minority Interests (P&L)
-2.54MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
191.53MCNYFY2025 · Dec 31, 2025
Free Cash Flow
-65.27MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
336.21MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
33.48MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
149.67MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-22.58MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
30.96MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-256.80MCNYFY2025 · Dec 31, 2025
Net Acquisitions
-161.93MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-418.73MCNYFY2025 · Dec 31, 2025
Long-term Debt Issuance
1.14BCNYFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.13BCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-100.71MCNYFY2025 · Dec 31, 2025
Other Financing Charges
138.10MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
44.90MCNYFY2025 · Dec 31, 2025
Shares Outstanding
3.45BSharesUpdated Sep 19, 2026
Float Shares
2.02BSharesUpdated Sep 19, 2026
% Held by Insiders
37.02%
vs all stocks
Updated Sep 19, 2026
% Held by Institutions
4.05%
vs all stocks
Updated Sep 19, 2026
Total Cash (MRQ)
368.32MCNY
54.94M · vs all stocks (USD)
Updated Sep 19, 2026
Total Cash per Share (MRQ)
0.1170CNYUpdated Sep 19, 2026
Total Debt (MRQ)
2.50BCNY
372.34M · vs all stocks (USD)
Updated Sep 19, 2026
Total Debt to Equity (MRQ)
1.23x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Current Ratio (MRQ)
0.5510x
vs Medical Care Facilities peers
Updated Sep 19, 2026
Book Value per Share (MRQ)
0.6280CNYUpdated Sep 19, 2026
Total Assets
6.65BCNY
991.54M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
1.91BCNYFY2025 · Dec 31, 2025
Total Liabilities
4.64BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
4.74BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
1.09BCNYFY2025 · Dec 31, 2025
Total Current Liabilities
3.54BCNYFY2025 · Dec 31, 2025
Cash
339.56MCNYFY2025 · Dec 31, 2025
Cash Equivalents
53.93MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
393.49MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
2.86MCNYFY2025 · Dec 31, 2025
Accounts Receivable
1.22BCNYFY2025 · Dec 31, 2025
Inventory
151.26MCNYFY2025 · Dec 31, 2025
Accounts Payable
1.50BCNYFY2025 · Dec 31, 2025
Short-term Debt
1.40BCNYFY2025 · Dec 31, 2025
Other Current Liabilities
63.17MCNYFY2025 · Dec 31, 2025
Long-term Debt
472.08MCNYFY2025 · Dec 31, 2025
Other Non-current Liabilities
157.78MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
3.39BCNYFY2025 · Dec 31, 2025
Retained Earnings
-2.93BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.01BCNY
300.10M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
166.95MCNYFY2025 · Dec 31, 2025
52-Week Low
1.69CNYUpdated Sep 19, 2026
52-Week High
2.97CNYUpdated Sep 19, 2026
52-Week Change
-10.26%
vs all stocks
Updated Sep 19, 2026
Beta
0.2190x
vs all stocks
Updated Sep 19, 2026
50-Day MA
2.16CNYUpdated Sep 19, 2026
200-Day MA
2.24CNYUpdated Sep 19, 2026
Avg 10-Day Volume
80.92MSharesUpdated Sep 19, 2026
Avg 30-Day Volume
135.68MSharesUpdated Sep 19, 2026
Diluted EPS (TTM)
0.0100CNYUpdated Sep 19, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
The price sits below its 40-week average, on three profitable years and cash above profit.
Reads
Where is this company structurally exposed?
Receivables Heavy and Growing
Money owed by customers keeps growing, and is much of its current assets.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Peer Positioning
Current ratio is 0.55×, lower than 95% of its Medical Care Facilities peers (median 1.29×)Significant
Current ratio: 0.55Industry median: 1.29Industry P5: 0.67Peers compared: 33.00
P/E ratio is 212×, higher than 95% of its Medical Care Facilities peers (median 20.61×)Significant